Studies that employed genetic depletion of PYCR1 have confirmed a functional role for PYCR1 in promoting tumor progression and cancer cell survival in colorectal cancer cells104, NSCLC cells42,97,98, renal cancer cells64,103, prostate cancer cells105, and IDH1-mutant gliomas106. This evidence concerns the gene IDH1 and prostate cancer.